Access Toxo IgG
Enzyme Linked Immunoabsorbent Assay, Toxoplasma Gondii. 510(k) K242022, from Beckman Coulter, Inc. (Chaska, MN). Product code LGD, class 2.
As of Nov 21, 2026, K242022 is an FDA 510(k) held by Beckman Coulter, Inc., substantially equivalent on Mar 28, 2025 after 260 days, with no recalls tied to it in FDA's recall database.
- Review time: 260 days
- Recalls: 0
The Access Toxo IgG assay is a paramagnetic-particle, chemiluminescent immunoassay for the qualitative and quantitative determination of IgG antibodies to Toxoplasma gondii in human serum using the Access Immunoassay Systems. The Access Toxo IgG assay aids in the diagnosis of Toxoplasma gondii infection and may be used to assess the immune status of pregnant women.
- Access Toxo Igg, Access Toxo Igg Calibrators and Access Toxo Igg QCK080869 · Beckman Coulter, Inc. · May 23, 2008
- Access Toxo IgM IIK242095 · Beckman Coulter, Inc. · Oct 11, 2024
- Alinity i Toxo IgMK233932 · Abbott Laboratories · Aug 30, 2024
- ARCHITECT Toxo IgGK210596 · Abbott Laboratories · May 19, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jul 11, 2024
- Review panel
- Microbiology
- Regulation
- 21 CFR 866.3780
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files